# Legend Biotech (LEGN) — Analyst Forecast

LEGN · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/legn/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 12 | 5 | 0 | 17 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $24.00 | $45.38 | $68.00 | 8 |

Last price $19.80 (as of Oct 16, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 13, 2026 | Barclays | Maintained | Overweight | $68.00 |
| Oct 9, 2026 | JP Morgan | Maintained | Neutral | $33.00 |
| Oct 8, 2026 | RBC Capital | Maintained | Outperform | $56.00 |
| Sep 30, 2026 | HC Wainwright & Co. | Maintained | Buy | $65.00 |
| Sep 11, 2026 | Barclays | Maintained | Overweight | $74.00 |
| Sep 4, 2026 | HC Wainwright & Co. | Maintained | Buy | $65.00 |
| Aug 12, 2026 | Barclays | Maintained | Overweight | $78.00 |
| Aug 12, 2026 | RBC Capital | Maintained | Outperform | $58.00 |
| Aug 12, 2026 | Oppenheimer | Downgraded | Outperform → Perform | $40.00 |
| Aug 12, 2026 | Morgan Stanley | Maintained | Overweight | $49.00 |
| Aug 12, 2026 | TD Cowen | Maintained | Hold | $24.00 |
| Jul 28, 2026 | HC Wainwright & Co. | Maintained | Buy | $65.00 |
| Jul 27, 2026 | RBC Capital | Maintained | Outperform | $59.00 |
| Jul 24, 2026 | UBS | Downgraded | Buy → Neutral | $28.00 |
| Jul 13, 2026 | JP Morgan | Maintained | Neutral | $35.00 |
| Jul 7, 2026 | RBC Capital | Maintained | Outperform | $63.00 |
| Jun 3, 2026 | HC Wainwright & Co. | Maintained | Buy | $65.00 |
| Jun 3, 2026 | UBS | Maintained | Buy | $49.00 |
| May 18, 2026 | HC Wainwright & Co. | Maintained | Buy | $50.00 |
| May 13, 2026 | RBC Capital | Maintained | Outperform | $64.00 |

## Frequently Asked Questions

### What is the price target for LEGN stock?

The average 12-month analyst price target for Legend Biotech (LEGN) is $45.38, with a high estimate of $68.00 and a low of $24.00, across 8 analysts.

### Is LEGN a buy, sell, or hold?

Analysts covering Legend Biotech currently average a Buy rating: 12 buy, 5 hold and 0 sell, from 17 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for LEGN?

The average price target of $45.38 implies 129.17% upside from the last price of $19.80.

### What is the latest analyst rating on LEGN?

On Oct 13, 2026, Barclays maintained Legend Biotech at Overweight with a price target of $68.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).